Aims-To determine the level of proliferative activity in 39 nasal poly
ps with clear cut distinct clinical behaviour patterns. Methods-The 39
nasal polyps included 11 polyps labelled as ''single'' and taken from
the lateral nasal wall and the middle turbinate; 12 polyps labelled a
s ''massive'' and relating to diffuse polyposis involving the entire n
asal cavity; six polyps labelled as ''ASA'' and relating to nasal poly
ps from patients with acetylsalicylic acid intolerance and asthma; and
10 polyps from cystic fibrosis related polyposis. Cell proliferation
was determined by two independent methods: first, the computer assiste
d microscope analysis of isolated Feulgen stained nuclei for the measu
rement of the percentage of cells in the S phase of the cell cycle; an
d second, the immunohistochemical evaluation of a proliferation associ
ated protein by means of the MIB 1 monoclonal antibody. Results-The cy
stic fibrosis related polyposis exhibited the highest proliferative ac
tivity of all the clinically identified nasal polyp groups. Acute infl
ammatory nasal polyps exhibited a higher cell proliferation than chron
ic ones. The results also show that while the immunohistochemical dete
rmination of cell proliferation by means of the MIB 1 monoclonal antib
ody is a valuable tool in determining cell proliferation in nasal poly
ps, the cytometrical image analysis of Feulgen stained nuclei is not u
seful for this purpose. Conclusion-Cell proliferation activity identif
ies cystic fibrosis as being distinct from the other nasal polyp group
s.